TAG ARCHIVE

POSTS TAGGED AS FDA

Digital Health Devices in Clinical Trials

January 8, 2019 | | Posted in Newsletter

Digital devices and clinical trials J
Five issues confront digital devices moving into clinical practice: usability, accuracy, safety, convenience, ease of [MORE]

Stem Cell Cosmetology, or How to Grow Bones in Your Eyes

February 5, 2013 | | Posted in Newsletter

Stem Cells for Cosmetic Surgery
Regenerative medicine holds many wonders, but not without worries too.  This piece tells how plastic surgeons [MORE]

Soup to Nuts for Innovators

May 1, 2012 | | Posted in Newsletter

In a new handbook that guides innovators through a process from discovery to the marketplace, Richard J. McMurtrey, M. [MORE]

For Toxicity Testing, a Human-Body-on-a-Chip

November 8, 2011 | | Posted in Newsletter

Over the next five years, the National Institutes of Health, the Defense Advanced Research Projects Agency (DARPA) and the [MORE]

Instant Coffee: Who Knew?

July 6, 2010 | | Posted in Newsletter

Tagline rarely includes news about drugs, much less nutritional supplements, but this piece-an FDA warning about Magic Power Coffee, [MORE]

FDA Reviews Infusion Pump Risks

May 25, 2010 | | Posted in Newsletter

The infusion pump is a ubiquitous piece of hospital equipment, often at a 3:1 ratio to the number of [MORE]

Analytics for Medical Device Clinical Trials

April 6, 2010 | | Posted in Newsletter

The FDA recently issued guidelines for using Bayesian statistical methods to correlate data from current and earlier clinical trials [MORE]

Device Advice

July 28, 2009 | | Posted in Newsletter

There aren’t many, if any, better sources of information about medical devices than the FDA’s website “Device Advice.”  It gives [MORE]

Patenting “Biosimilars”

May 27, 2009 | | Posted in Newsletter

Several bills now in Congress could result in a fundamental change to patenting biologics (such as monoclonal antibodies).  One bill [MORE]

FDA Approves First Drug from Genetically Engineered Animal

February 24, 2009 | | Posted in Newsletter

The FDA has approved GTC Biotherapeutics’ (Framingham, MA) antithrombin alpha from genetically engineered goats.  For more than a decade, recombinant [MORE]

FDA Policy on Class III Devices

February 3, 2009 | | Posted in Newsletter

The Obama administration likely will have the FDA review its approval processes for all Class III medical devices (i.e. those [MORE]

FDA Approved Five More i-STAT Tests

January 28, 2009 | | Posted in Newsletter

Abbott’s i-STAT handheld blood analyzer has just received an FDA waiver for five more tests using its 18 cartridges, which [MORE]

Designing Drug-Eluting Stents

January 28, 2009 | | Posted in Newsletter

Stent
There are currently only four drug-eluting stents under FDA approval, and their effectiveness or ineffectiveness have been called into question.  [MORE]

Clinical Trial Participation

December 9, 2008 | | Posted in Newsletter

With a noticeable shift from small molecules to biologicals, it’s no surprise that The Philadelphia Business Journal reports that biopharma [MORE]